Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4368-4377

  Griffiths, Mark R ^a   Neal, Jim W ^a   Fontaine, Marc ^b   Das, Trina ^c   Gasque, Philippe ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ DE ROUEN   (France)

^c University of La Reunion   (Reunion)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN; CD22 ANTIGEN; CD47 ANTIGEN; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; FRACTALKINE; SEMAPHORIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; AXONAL INJURY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; OPSONIZATION; PERIKARYON; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ANIMAL; BRAIN; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; COMPLEMENT FACTOR H; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEURONS;

EID: 64249098087     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800205     Document Type: Article

References (70)

1. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927-930. (Pubitemid 36044685)
2. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
3. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485.
4. Barnum, S. R., Y. Ishii, A. Agrawal, and J. E. Volanakis. 1992. Production and interferon-γ-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. Biochem. J. 287: 595-601.
5. Canova, C., J. W. Neal, and P. Gasque. 2006. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J Neuroinflamm. 3: 22. (Pubitemid 44463617)
6. Gasque, P., A. Ischenko, J. Legoedec, C. Mauger, M. T. Schouft, and M. Fontaine. 1993. Expression of the complement classical pathway by human glioma in culture: a model for complement expression by nerve cells. J. Biol. Chem. 268: 25068-25074. (Pubitemid 23335530)
7. Gasque, P., J. Jones, S. K. Singhrao, and B. Morgan. 1998. Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense. J. Exp. Med. 187: 451-460. (Pubitemid 28093347)
8. Gasque, P., N. Julen, A. M. Ischenko, C. Picot, C. Mauger, C. Chauzy, J. Ripoche, and M. Fontaine. 1992. Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149: 1381-1387.
9. Nguyen, M. D., J. P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216-227. (Pubitemid 135706591)
10. Schwartz, M., G. Moalem, R. Leibowitz-Amit, and I. R. Cohen. 1999. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22: 295-299. (Pubitemid 29307803)
11. Elward, K., and P. Gasque. 2003. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol. Immunol. 40: 85-94. (Pubitemid 36959819)
12. Elward, K., M. Griffiths, M. Mizuno, C. L. Harris, J. W. Neal, B. P. Morgan, and P. Gasque. 2005. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280: 36342-36354. (Pubitemid 41633908)
13. Laflamme, N., and S. Rivest. 2001. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15: 155-163. (Pubitemid 32061666)
14. Hauwel, M., E. Furon, C. Canova, M. Griffiths, J. Neal, and P. Gasque. 2005. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48: 220-233.
15. Gendelman, H. E. 2002. Neural immunity: Friend or foe? J. Neurovirol. 8: 474-479.
16. Lehnardt, S., L. Massillon, P. Follett, F. E. Jensen, R. Ratan, P. A. Rosenberg, J. J. Volpe, and T. Vartanian. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 100: 8514-8519. (Pubitemid 36842576)
17. Ma, Y., J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lu, B. Kosaras, R. L. Sidman, J. J. Volpe, and T. Vartanian. 2006. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175: 209-215. (Pubitemid 44631415)
18. McGeer, P. L., and E. G. McGeer. 2002. Innate immunity, local inflammation, and degenerative disease. Sci Aging Knowledge Environ. 2002: re3.
19. Mead, R. J., S. K. Singhrao, J. W. Neal, H. Lassmann, and B. P. Morgan. 2002. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 168: 458-465.
20. Minghetti, L. 2005. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18: 315-321.
21. Prinz, M., F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, K. Wolter, M. Piesche, R. Schroers, E. Weiss, C. J. Kirschning, et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464. (Pubitemid 43228363)
22. Marin-Teva, J. L., I. Dusart, C. Colin, A. Gervais, N. van Rooijen, and M. Mallat. 2004. Microglia promote the death of developing Purkinje cells. Neuron 41: 535-547.
23. Griffiths, M., J. W. Neal, and P. Gasque. 2007. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins (NIRegs). Int. Rev. Neurobiol. 82: 29-55.
24. Grimsley, C., and K. S. Ravichandran. 2003. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 13: 648-656. (Pubitemid 37415030)
25. Cardona, A. E., E. P. Pioro, M. E. Sasse, V. Kostenko, S. M. Cardona, I. M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, R. Dutta, et al. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9: 917-924.
26. Czopik, A. K., M. S. Bynoe, N. Palm, C. S. Raine, and R. Medzhitov. 2006. Semaphorin 7A is a negative regulator of T cell responses. Immunity 24: 591-600.
27. Gardai, S. J., K. A. McPhillips, S. C. Frasch, W. J. Janssen, A. Starefeldt, J. E. Murphy-Ullrich, D. L. Bratton, P. A. Oldenborg, M. Michalak, and P. M. Henson. 2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-334.
28. Hoek, R. M., S. R. Ruuls, C. A. Murphy, G. J. Wright, R. Goddard, S. M. Zurawski, B. Blom, M. E. Homola, W. J. Streit, M. H. Brown, et al. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768-1771.
29. Majed, H. H., S. Chandran, S. P. Niclou, R. S. Nicholas, A. Wilkins, M. G. Wing, K. E. Rhodes, M. G. Spillantini, and A. Compston. 2006. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J. Neurosci. 26: 1730-1738.
30. Mott, R. T., G. Ait-Ghezala, T. Town, T. Mori, M. Vendrame, J. Zeng, J. Ehrhart, M. Mullan, and J. Tan. 2004. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46: 369-379.
31. Singhrao, S. K., J. W. Neal, B. P. Morgan, and P. Gasque. 1999. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 159: 362-376.
32. Singhrao, S. K., J. W. Neal, N. K. Rushmere, B. P. Morgan, and P. Gasque. 2000. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Am. J. Pathol. 157: 905-918.
33. Thomas, A., P. Gasque, D. Vaudry, B. Gonzalez, and M. Fontaine. 2000. Expression of a complete and functional complement system by human neuronal cells in vitro. Int. Immunol. 12: 1015-1023. (Pubitemid 30599354)
34. van Beek, J., M. van Meurs, B. A. t Hart, H. P. Brok, J. W. Neal, A. Chatagner, C. L. Harris, N. Omidvar, B. P. Morgan, J. D. Laman, and P. Gasque. 2005. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J. Immunol. 174: 2353-2365.
35. Morgan, B. P., and P. Gasque. 1996. Expression of complement in the brain: role in health and disease. Immunol. Today 17: 461-466. (Pubitemid 26323314)
36. Davoust, N., S. Nataf, R. Reiman, M. V. Holers, I. L. Campbell, and S. R. Barnum. 1999. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J. Immunol. 163: 6551-6556.
37. Barnum, S. R., and A. J. Szalai. 2006. Complement and demyelinating disease: no MAC needed? Brain Res. Rev. 52: 58-68.
38. Junnikkala, S., T. S. Jokiranta, M. A. Friese, H. Jarva, P. F. Zipfel, and S. Meri. 2000. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1. J. Immunol. 164: 6075-6081. (Pubitemid 30389858)
39. Dean, Y. D., E. P. McGreal, H. Akatsu, and P. Gasque. 2000. Molecular and cellular properties of the rat AA4 antigen, a C-type lectin-like receptor with structural homology to thrombomodulin. J. Biol. Chem. 275: 34382-34392.
40. Ripoche, J., A. Al Salihi, J. Rousseaux, and M. Fontaine. 1984. Isolation of two molecular populations of human complement factor H by hydrophobic affinity chromatography. Biochem. J. 221: 89-96. (Pubitemid 14082295)
41. Linington, C., H. Lassmann, B. P. Morgan, and D. A. Compston. 1989. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis. Acta Neuropathol. 79: 78-85. (Pubitemid 19259293)
42. Spiller, O. B., S. M. Hanna, and B. P. Morgan. 1999. Tissue distribution of the rat analogue of decay-accelerating factor. Immunology 97: 374-384. (Pubitemid 29314632)
43. Norgren, N., A. Edelstam, and T. Stigbrand. 2005. Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis. Brain Res. Bull. 67: 264-268. (Pubitemid 41354775)
44. Abeyama, K., D. M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, M. Tanaka, T. Uchimura, N. Ida, Y. Yamazaki, S. Yamada, et al. 2005. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115: 1267-1274. (Pubitemid 40629045)
45. Ennas, M. G., D. Cocchia, E. Silvetti, V. Sogos, A. Riva, S. Torelli, and F. Gremo. 1992. Immunocompetent cell markers in human fetal astrocytes and neurons in culture. J. Neurosci. Res. 32: 424-436.
46. Fassbender, K., S. Walter, S. Kuhl, R. Landmann, K. Ishii, T. Bertsch, A. K. Stalder, F. Muehlhauser, Y. Liu, A. J. Ulmer, et al. 2004. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18: 203-205.
47. Fukuda, M., and S. R. Carlsson. 1986. Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens. Med. Biol. 64: 335-343. (Pubitemid 17226776)
48. Simmons, D. L., C. Walker, C. Power, and R. Pigott. 1990. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 171: 2147-2152.
49. Turley, E. A., M. Z. Hossain, T. Sorokan, L. M. Jordan, and J. I. Nagy. 1994. Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia 12: 68-80.
50. Jha, P., J. H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora. 2006. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J. Immunol. 176: 7221-7231. (Pubitemid 43849022)
51. Kaminski, H. J., Z. Li, C. Richmonds, F. Lin, and M. E. Medof. 2004. Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis. Exp. Neurol. 189: 333-342. (Pubitemid 39221825)
52. Mizuno, M., K. Nishikawa, O. B. Spiller, B. P. Morgan, N. Okada, H. Okada, and S. Matsuo. 2001. Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats. Arthritis Rheum. 44: 2425-2434. (Pubitemid 32977512)
53. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P. Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152: 5477-5484. (Pubitemid 2102028)
54. Nataf, S., S. L. Carroll, R. A. Wetsel, A. J. Szalai, and S. R. Barnum. 2000. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165: 5867-5873.
55. Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102: 7227-7232.
56. Hye, A., S. Lynham, M. Thambisetty, M. Causevic, J. Campbell, H. L. Byers, C. Hooper, F. Rijsdijk, S. J. Tabrizi, S. Banner, et al. 2006. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129: 3042-3050. (Pubitemid 44684524)
57. Strohmeyer, R., M. Ramirez, G. J. Cole, K. Mueller, and J. Rogers. 2002. Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J Neuroimmunol. 131: 135-146.
58. Zipfel, P. F., J. Misselwitz, C. Licht, and C. Skerka. 2006. The role of defective complement control in hemolytic uremic syndrome. Semin. Thromb. Hemostasis 32: 146-154.
59. Malhotra, V., and R. B. Sim. 1985. Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur. J. Immunol. 15: 935-941. (Pubitemid 15229761)
60. Fasani, F., A. Bocquet, P. Robert, A. Peterson, and J. Eyer. 2004. The amount of neurofilaments aggregated in the cell body is controlled by their increased sensitivity to trypsin-like proteases. J. Cell Sci. 117: 861-869. (Pubitemid 38386943)
61. Pickering, M. C., H. T. Cook, J. Warren, A. E. Bygrave, J. Moss, M. J. Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31: 424-428.
62. Fedarko, N. S., B. Fohr, P. G. Robey, M. F. Young, and L. W. Fisher. 2000. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J. Biol. Chem. 275: 16666-16672.
63. Kraiczy, P., J. Hellwage, C. Skerka, M. Kirschfink, V. Brade, P. F. Zipfel, and R. Wallich. 2003. Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur. J. Immunol. 33: 697-707. (Pubitemid 36367673)
64. Perez-Caballero, D., I. Garcia-Laorden, G. Cortes, M. R. Wessels, S. R. de Cordoba, and S. Alberti. 2004. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules. J. Immunol. 173: 6899-6904. (Pubitemid 39541077)
65. Avery, V. M., and D. L. Gordon. 1993. Characterization of factor H binding to human polymorphonuclear leukocytes. J. Immunol. 151: 5545-5553. (Pubitemid 23332364)
66. DiScipio, R. G., P. J. Daffern, I. U. Schraufstatter, and P. Sriramarao. 1998. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves αMβ2 (CD11b/CD18). J. Immunol. 160: 4057-4066.
67. Serrano, J., J. M. Encinas, A. P. Fernandez, S. Castro-Blanco, D. Alonso, P. Fernandez-Vizarra, A. Richart, M. L. Bentura, M. Santacana, F. Cuttitta, et al. 2003. Distribution of immunoreactivity for the adrenomedullin binding protein, complement factor H, in the rat brain. Neuroscience 116: 947-962. (Pubitemid 36262953)
68. Wu, R., M. Zhou, and P. Wang. 2003. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-α in macrophage cell line and rat Kupffer cells. Regul. Pept. 112: 19-26. (Pubitemid 36351599)
69. Serrano, J., D. Alonso, J. M. Encinas, J. C. Lopez, A. P. Fernandez, S. Castro-Blanco, P. Fernandez-Vizarra, A. Richart, M. L. Bentura, M. Santacana, et al. 2002. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience 109: 717-731. (Pubitemid 34260856)
70. Watanabe, K., M. Takayasu, A. Noda, M. Hara, T. Takagi, Y. Suzuki, and J. Yoshia. 2001. Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir. 143: 1157-1161. (Pubitemid 33078443)